Oral Magnesium Supplementation in Chronic Kidney Disease Stages 3 and 4: Efficacy, Safety, and Effect on Serum Calcification Propensity—A Prospective Randomized Double-Blinded Placebo-Controlled Clinical Trial

INTRODUCTION: Chronic kidney disease (CKD) is associated with high cardiovascular morbidity and mortality. Recent evidence suggests that increases in both serum and intracellular magnesium (Mg) can slow or even prevent the development of vascular calcification seen in CKD. Serum calcification propen...

Descripción completa

Detalles Bibliográficos
Autores principales: Bressendorff, Iain, Hansen, Ditte, Schou, Morten, Silver, Burton, Pasch, Andreas, Bouchelouche, Pierre, Pedersen, Lise, Rasmussen, Lars Melholt, Brandi, Lisbet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678662/
https://www.ncbi.nlm.nih.gov/pubmed/29142966
http://dx.doi.org/10.1016/j.ekir.2016.12.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678662/
https://www.ncbi.nlm.nih.gov/pubmed/29142966
http://dx.doi.org/10.1016/j.ekir.2016.12.008

Ejemplares similares